Source link : https://www.newshealth.biz/health-news/benralizumab-led-to-histologic-responses-in-eosinophilic-esophagitis/
More patients with eosinophilic esophagitis experienced a histologic response with benralizumab (Fasenra) compared with placebo, despite similar levels of continuing symptoms in the two groups at 24 weeks, the phase III randomized MESSINA trial showed. Among 211 patients ages 12 to 65 years, 87.4% of those receiving benralizumab had a histologic response — defined as […]
Author : News Health
Publish date : 2024-06-26 21:00:00
Copyright for syndicated content belongs to the linked Source.
Categories